- Title: Subtitle
- 9 - Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/ Refractory Large B-Cell Lymphoma (R/R LBCL): 1-Year Follow-up of Zuma-1 Cohort 6 (C6)
- Creators
- Olalekan O. OluwoleEdouard ForcadeJavier MuñozSophie de GuibertJulie M. VoseNancy L BartlettYi LinAbhinav DeolPeter A McSweeneyAndre H. GoyMarie José KerstenCaron A. JacobsonUmar FarooqMonique C. MinnemaCatherine ThieblemontJohn M. TimmermanPatrick StiffIrit AviviDimitrios TzachanisJenny J. KimYan ZhengRhine R ShenSaran VardhanabhutiTom van Meerten
- Resource Type
- Abstract
- Publication Details
- Transplantation and cellular therapy, Vol.28(3), pp.S9-S9
- DOI
- 10.1016/S2666-6367(22)00170-1
- ISSN
- 2666-6367
- eISSN
- 2666-6367
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 03/2022
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984362737402771
Abstract
9 - Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/ Refractory Large B-Cell Lymphoma (R/R LBCL): 1-Year Follow-up of Zuma-1 Cohort 6 (C6)
Transplantation and cellular therapy, Vol.28(3), pp.S9-S9
03/2022
DOI: 10.1016/S2666-6367(22)00170-1
Details
Metrics
36 Record Views